Orion Oyj Management
Management criteria checks 3/4
Orion Oyj's CEO is Liisa Hurme, appointed in Jan 2019, has a tenure of 5.92 years. total yearly compensation is €819.50K, comprised of 81.6% salary and 18.4% bonuses, including company stock and options. directly owns 0.023% of the company’s shares, worth €1.35M. The average tenure of the management team and the board of directors is 2.1 years and 4.6 years respectively.
Key information
Liisa Hurme
Chief executive officer
€819.5k
Total compensation
| CEO salary percentage | 81.6% |
| CEO tenure | 5.9yrs |
| CEO ownership | 0.02% |
| Management average tenure | 2.1yrs |
| Board average tenure | 4.6yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | €332m |
| Jun 30 2024 | n/a | n/a | €232m |
| Mar 31 2024 | n/a | n/a | €217m |
| Dec 31 2023 | €820k | €668k | €217m |
| Sep 30 2023 | n/a | n/a | €173m |
| Jun 30 2023 | n/a | n/a | €306m |
| Mar 31 2023 | n/a | n/a | €336m |
| Dec 31 2022 | €106k | €106k | €350m |
Compensation vs Market: Liisa's total compensation ($USD849.22K) is about average for companies of similar size in the Finnish market ($USD1.01M).
Compensation vs Earnings: Liisa's compensation has increased by more than 20% in the past year.
CEO
Liisa Hurme (57 yo)
5.9yrs
Tenure
€819,500
Compensation
Dr. Liisa Hurme, PhD (Biochemistry), has been President , Chief Executive Officer and Chairman of Managemenbt board at Orion Oyj since Novemnber 01, 2022. Dr. Hurme served as Senior Vice President, Global...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| President | 5.9yrs | €819.50k | 0.023% € 1.4m | |
| Chief Financial Officer & Member of Group Executive Management Board | less than a year | no data | no data | |
| Senior VP of Corporate Functions | 22.2yrs | no data | 0.060% € 3.5m | |
| Senior VP of Generics and Consumer Health Business Division & Member of the Exe. Mgmt. Board | 16.9yrs | no data | 0.025% € 1.5m | |
| Sr. VP of Innovative Medicines | 4.5yrs | no data | 0.010% € 606.3k | |
| Senior VP of Global Operations & Member of Executive Management Board | 2.1yrs | no data | 0.0036% € 211.6k | |
| Senior VP of Animal Health Business Division & Member of the Exe. Mgmt. Board | 1.9yrs | no data | 0.0031% € 181.3k | |
| Senior VP of the Branded Products Business Division & Member of the Exe. Mgmt. Board | 1.9yrs | no data | 0.010% € 616.9k | |
| Senior Vice President of People & Culture and Member of Management Board | less than a year | no data | no data | |
| Investor Relations & Financial Communications Officer | no data | no data | no data | |
| Vice President of Communications | 15.7yrs | no data | no data | |
| Sr. VP of Corporate Strategy and Program Mgmt. Grp. Level Function & Head of CSPMO | less than a year | no data | 0.023% € 1.4m |
2.1yrs
Average Tenure
55yo
Average Age
Experienced Management: ORNAV's management team is considered experienced (2.1 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Independent Director | 10.8yrs | €123.40k | 0.0069% € 410.7k | |
| Independent Chairman | 3.8yrs | €61.40k | 0.0066% € 391.1k | |
| Director | less than a year | no data | no data | |
| Independent Director | 4.6yrs | €61.40k | 0.062% € 3.7m | |
| Independent Director | 7.8yrs | €72.40k | 0.0036% € 215.1k | |
| Independent Director | 2.8yrs | €60.80k | 0.0011% € 64.0k | |
| Independent Director | 8.8yrs | €61.40k | 0.41% € 24.3m | |
| Independent Vice Chairman of the Board | 7.8yrs | €81.10k | 0.0073% € 430.8k | |
| Independent Director | 2.8yrs | €66.80k | 0.0011% € 64.0k |
4.6yrs
Average Tenure
62yo
Average Age
Experienced Board: ORNAV's board of directors are considered experienced (4.6 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/19 06:19 |
| End of Day Share Price | 2024/12/19 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Orion Oyj is covered by 18 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Peter Ankersen | ABG Sundal Collier |
| Graham Glyn Parry | BofA Global Research |
| Kristofer Liljeberg-Svensson | Carnegie Investment Bank AB |